cd38 inhibitor benefits with 5-amino-1mq Anti-CD38 antibody therapy for patients relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes | Annals of Hematology Selective and membrane-permeable small molecule
Selective and membrane permeable small molecule inhibitors of nicotinamide N methyltransferase reverse high fat diet induced obesity in mice PMC A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect 5 Amino 1MQ Benefits, Safety, and Uses Evolving Therapeutics in Multiple Myeloma Empower MM Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma Bisht 2023 Cancer Medicine Wiley Online Library Discovery of a First in Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




